ConductScience.org, home

Paper39669588

Cancer burden in individuals with single versus double pathogenic variants in cancer susceptibility genes.

Agaoglu NB and 11 others. Genet Med Open, 2024. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Cancer burden in individuals with single versus double pathogenic variants in cancer susceptibility genes. Papers, record 39669588. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39669588

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cancer burden in individuals with single versus double pathogenic variants in cancer susceptibility genes.
PubMed
Journal
Genet Med Open
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
1.6, provisional
iCite
Revised in PubMed
2024-12-14
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Agaoglu NBNihat B
2Bychkovsky BLBrittany L
3Horton CCarolyn
4Lo MTMin-Tzu
5Polfus LLinda
6Carraway CCassidy
7Hemyari PParichehr
8Young CColin
9Richardson MEMarcy E
10Scheib RRochelle
11Garber JEJudy E
12Rana HQHuma Q

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124800916Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.Breast Cancer Res Treat2014https://conductscience.org/library/papers/24800916PubMed
236003761Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer.Front Oncol2022https://conductscience.org/library/papers/36003761PubMed
322535016Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management.Breast Cancer Res Treat2012https://conductscience.org/library/papers/22535016PubMed
431993860High risk of breast cancer in women with biallelic pathogenic variants in CHEK2.Breast Cancer Res Treat2020https://conductscience.org/library/papers/31993860PubMed
520091130Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain.Fam Cancer2010https://conductscience.org/library/papers/20091130PubMed
629153097Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories.Cancer Genet2017https://conductscience.org/library/papers/29153097PubMed
710733235Assessment of education and counselling offered by a familial colorectal cancer clinic.Clin Genet2000https://conductscience.org/library/papers/10733235PubMed
831406321A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients.Genet Med2020https://conductscience.org/library/papers/31406321PubMed
931201024Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines.J Mol Diagn2019https://conductscience.org/library/papers/31201024PubMed
1021075289Mouse models of inherited cancer syndromes.Hematol Oncol Clin North Am2010https://conductscience.org/library/papers/21075289PubMed
1118246448Inequality of use of cancer genetics services by members of breast, ovarian and colorectal cancer families in South East Scotland.Fam Cancer2008https://conductscience.org/library/papers/18246448PubMed
1232948847Barriers and facilitators for cascade testing in genetic conditions: a systematic review.Eur J Hum Genet2020https://conductscience.org/library/papers/32948847PubMed
1321921926Haplotype phasing: existing methods and new developments.Nat Rev Genet2011https://conductscience.org/library/papers/21921926PubMed
1427836010Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.Breast Cancer Res2016https://conductscience.org/library/papers/27836010PubMed
1532743790Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals.Fam Cancer2021https://conductscience.org/library/papers/32743790PubMed
1634875721Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics.Cancer2022https://conductscience.org/library/papers/34875721PubMed
1732777875Uptake of Family-Specific Mutation Genetic Testing Among Relatives of Patients with Ovarian Cancer with BRCA1 or BRCA2 Mutation.Cancer Res Treat2021https://conductscience.org/library/papers/32777875PubMed
1836136322Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care-Checking CHEK2.JAMA Oncol2022https://conductscience.org/library/papers/36136322PubMed
1934637943Concurrent pathogenic variations in patients with hereditary cancer syndromes.Eur J Med Genet2021https://conductscience.org/library/papers/34637943PubMed
2025741868
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Genet Med2015https://conductscience.org/library/papers/25741868PubMed

Download CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42258060Characterization of the molecular and clinical features of Multilocus Inherited Neoplasia Allelic Syndrome (MINAS) cases in the Turkish population.Fam Cancer2026https://conductscience.org/library/papers/42258060PubMed
41487526Multilocus inherited neoplasia allele syndrome (MINAS) in a Turkish cohort: molecular insights and clinical relevance for precision oncology.Front Pharmacol2025https://conductscience.org/library/papers/41487526PubMed
41228253Advances in Hereditary Colorectal Cancer: How Precision Medicine Is Changing the Game.Cancers (Basel)2025https://conductscience.org/library/papers/41228253PubMed
40943312Double Pathogenic or Likely Pathogenic Variants in Cancer Predisposition Genes in Hungarian Cancer Patients.Int J Mol Sci2025https://conductscience.org/library/papers/40943312PubMed
39594831Molecular and In Silico Analysis of the CHEK2 Gene in Individuals with High Risk of Cancer Predisposition from Türkiye.Cancers (Basel)2024https://conductscience.org/library/papers/39594831PubMed
39539798Hereditary and clinical insights into paraganglioma and pheochromocytoma.Endocr Oncol2024https://conductscience.org/library/papers/39539798PubMed
39353430Phenotypic spectrum of dual diagnoses in developmental disorders.Am J Hum Genet2024https://conductscience.org/library/papers/39353430PubMed
39317201Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variants.Am J Hum Genet2024https://conductscience.org/library/papers/39317201PubMed
38985133Genotype matters: Personalized screening recommendations for germline CHEK2 variants.Oncotarget2024https://conductscience.org/library/papers/38985133PubMed
38854136Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variants.medRxiv2024https://conductscience.org/library/papers/38854136PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
CHEK211200PubTator's text mininghttps://conductscience.org/library/genes/11200NCBI Gene
PALB279728PubTator's text mininghttps://conductscience.org/library/genes/79728NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39669588

GET https://conductscience.org/api/papers/v1/39669588/authors